Montelukast + Levocetirizine Tablet

Montelukast + Levocetirizine Tablet

Categories : Respiratory System

Product Packaging : 10x10 Blister

Product Composition : 10 mg + 5 mg

Send Message

Montelukast + Levocetirizine Tablets are combination antiallergic medications used for the effective management of allergic rhinitis, chronic urticaria, and respiratory allergic conditions. This dual-action formulation combines Levocetirizine, a selective H1 antihistamine, with Montelukast, a leukotriene receptor antagonist, providing comprehensive control over allergic responses.

Levocetirizine helps reduce histamine-mediated symptoms such as sneezing, itching, and runny nose, while Montelukast reduces airway inflammation and prevents bronchoconstriction. This combination therapy is widely prescribed for enhanced symptom relief and improved patient outcomes in allergy and respiratory care.

Genliva Wellness LLP is a trusted montelukast levocetirizine tablets contract manufacturer India, delivering high-quality formulations for domestic markets, global exports, and montelukast levocetirizine tablets third party manufacturer India services.

Montelukast and Levocetirizine tablets combine a leukotriene receptor antagonist with a modern antihistamine to provide comprehensive allergy control. The formulation targets multiple pathways involved in allergic reactions for improved symptom relief.

  • Dual-action mechanism blocking leukotrienes and histamine
  • Helps control both nasal and airway allergic responses
  • Provides long-lasting relief with once-daily dosing
  • Low sedative effect with good tolerability
  • Suitable for chronic and seasonal allergy management
  • Manufactured under stringent quality standards

 

This combination is widely used for the management of respiratory and allergic conditions. It helps reduce inflammation and improves overall breathing comfort.

  • Allergic rhinitis (seasonal and perennial)
  • Sneezing, runny nose, and nasal congestion
  • Allergic cough and airway inflammation
  • Supportive therapy in asthma
  • Relief from watery eyes and throat irritation

The formulation is designed to deliver enhanced allergy relief through a combination approach. It ensures better patient compliance and consistent therapeutic outcomes.

  • Combined anti-allergic and anti-inflammatory benefits
  • Once-daily dosing for improved convenience
  • Reduces frequency and severity of symptoms
  • Suitable for long-term use in chronic conditions
  • Stable formulation with reliable performance
  • Ideal for large-scale manufacturing and global distribution

 


whatsapp-app